Secular Trend of Hospital‐Acquired Candidemia among Intensive Care Unit Patients in the United States during 1989–1999
The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
We describe the annual incidence of primary bloodstream infection (BSI) associated with Candida albicans and common non-albicans species of Candida among patients in intensive care units that participated in the National Nosocomial Infections Surveillance system from 1 January 1989 through 31 December 1999. During the study period, there was a significant decrease in the incidence of C. albicans BSI (P<.001) and a significant increase in the incidence of Candida glabrata BSI (P=.05).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“there was a statistically significant increase in the rate of infections due to Candida glabrata, which is now the second most common cause of bloodstream and mucosal infections in the United States (6, 48, 65, 69).”
From Functional Genomic Analysis of Fluconazole Susceptibility in the Pathogenic Yeast Candida glabrata : Roles of Calcium Signaling and Mitochondria (2004) · cites this paper as [65]
In the citing paper
“there was a significant decrease in the annual incidence of infections with Candida albicans, the most common cause of Candida BSI, in this group of patients in the 1990s (40).”
In the citing paper
“During the same time period, there was a significant increase in the incidence of C. glabrata BSI (40).”
In the citing paper
“Although C. albicans continues to be the single most common species causing candidemia, results from this study confirm prior reports that, compared to the situation in the 1980s, a larger proportion of Candida BSI in the United States is now caused by Candida species other than C. albicans (20, 40).”
In the citing paper
“A significant increase in C. glabrata BSI was also noted (from 0.2 per 10,000 CVC days in 1989 to 0.5 per 10,000 CVC days in 1999; P = 0.05)”
4 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
CDC definitions for nosocomial infections, 1988
Garner, J. S., Jarvis, W. R., Emori, T. G., Horan, T. C., & Hughes, J. M. (1988) · American Journal of Infection Control · doi:10.1016/0196-6553(88)90053-3 · Cited by 5,672
CDC definitions for nosocomial infections
Yangco, B. G. (1989) · American Journal of Infection Control · doi:10.1016/s0196-6553(89)80013-6 · Cited by 3,770
Goodman, J. L., Winston, D. J., Greenfield, R. A., Chandrasekar, P. H., Fox, B., Kaizer, H., Shadduck, R. K., Shea, T. C., Stiff, P., Friedman, D. J., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199203263261301 · Cited by 1,174
Secular trends in nosocomial primary bloodstream infections in the United States, 1980–1989.
Banerjee, S. N., Emori, T. G., Culver, D. H., Gaynes, R. P., Jarvis, W. R., Horan, T., Edwards, J. R., Tolson, J., Henderson, T., Martone, W. J., et al. (1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)90349-3 · Cited by 880
Self-citationEpidemiology of nosocomial fungal infections
Fridkin, S. K., & Jarvis, W. R. (1996) · Clinical Microbiology Reviews · doi:10.1128/cmr.9.4.499 · Cited by 782
Self-citation1997 Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with Unexplained Fever
Hughes, W. T., Armstrong, D., Bodey, G. P., Brown, A. E., Edwards, J. E., Feld, R., Pizzo, P., Rolston, K. V. I., Shenep, J. L., & Young, L. S. (1997) · Clinical Infectious Diseases · doi:10.1086/513764 · Cited by 672
Self-citationNosocomial infection rates in adult and pediatric intensive care units in the United States
Jarvis, W. R., Edwards, J. R., Culver, D. H., Hughes, J. M., Horan, T., Emori, T. G., Banerjee, S., Tolson, J., Henderson, T., Gaynes, R. P., et al. (1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)90367-7 · Cited by 497
Self-citationKao, A. S., Brandt, M. E., Pruitt, W. R., Conn, L. A., Perkins, B. A., Stephens, D. S., Baughman, W. S., Reingold, A. L., Rothrock, G. A., Pfaller, M. A., et al. (1999) · Clinical Infectious Diseases · doi:10.1086/313450 · Cited by 457
Self-citationKomshian, S. V., Uwaydah, A. K., Sobel, J. D., & Crane, L. R. (1989) · Clinical Infectious Diseases · doi:10.1093/clinids/11.3.379 · Cited by 457
Risk Factors for Hospital-Acquired Candidemia: A Matched Case-Control Study
Wey, S. B. (1989) · Archives of Internal Medicine · doi:10.1001/archinte.1989.00390100145030 · Cited by 369
Research works printed but not linked: 3
- Jarvis WR, 1991, National Nosocomial Infections Surveillance System. Am J Med, 91, 185S
- 10.1001/archinte.149.10.2349 · DOI · Paper page
- National Nosocomial Infections Surveillance, 2000, MMWR Morb Mortal Wkly Rep, 49, 149
Cited by
Items 101–200 of 664
Colombo, A. L., Perfect, J. R., DiNubile, M. J., Bartizal, K. F., Motyl, M. R., Hicks, P. S., Lupinacci, R. J., Sable, C. A., & Kartsonis, N. A. (2003) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-003-0973-8 · Cited by 141
Immunity to Commensal Fungi: Detente and Disease
Wheeler, M. L., Limon, J. J., & Underhill, D. M. (2017) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathol-052016-100342 · Cited by 130
The changing epidemiology of fungal infections
Lass‐Flörl, C., & Steixner, S. J. M. (2023) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2023.101215 · Cited by 151
Changing Strategies for the Management of Invasive Fungal Infections
Rapp, R. P. (2004) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.24.3.4s.33151 · Cited by 125
Invasive candidiasis in immunocompromised hospitalized patients.
Sims, C. R., Ostrosky-Zeichner, L., & Rex, J. H. (2005) · Archives of Medical Research · doi:10.1016/j.arcmed.2005.05.015 · Cited by 124
Bassetti, M., Trecarichi, E. M., Righi, E., Sanguinetti, M., Bisio, F., Posteraro, B., Soro, O., Cauda, R., Viscoli, C., & Tumbarello, M. (2007) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2007.01.005 · Cited by 135
González, G. M., Elizondo, M., & Ayala, J. (2008) · Journal of Clinical Microbiology · doi:10.1128/jcm.00937-08 · Cited by 122
Filioti, J., Spiroglou, K., & Roilides, E. (2007) · Intensive Care Medicine · doi:10.1007/s00134-007-0672-5 · Cited by 132
Wong, S., Fares, M. A., Zimmermann, W., Butler, G., & Wolfe, K. H. (2003) · Genome Biology · doi:10.1186/gb-2003-4-2-r10 · Cited by 113
Zepelin, M. B.-V., Kunz, L., Rüchel, R., Reichard, U., Weig, M., & Groß, U. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm145 · Cited by 111
Antifungal Susceptibility Testing of Candida Isolates from the Candida Surveillance Study
Lyon, G. M., Karatela, S., Sunay, S., & Adiri, Y. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.02363-09 · Cited by 111
Candida glabrata and Candida albicans co‐infection of an in vitro oral epithelium
Silva, S., Henriques, M., Hayes, A., Oliveira, R., Azeredo, J., & Williams, D. W. (2011) · Journal of Oral Pathology & Medicine · doi:10.1111/j.1600-0714.2010.00981.x · Cited by 108
Mokaddas, E. M., Al-Sweih, N. A., & Khan, Z. U. (2007) · Journal of Medical Microbiology · doi:10.1099/jmm.0.46817-0 · Cited by 106
Caspofungin Activity against Clinical Isolates of Fluconazole-Resistant Candida
Pfaller, M. A., Messer, S. A., Boyken, L., Rice, C., Tendolkar, S., Hollis, R. J., & Diekema, D. J. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.12.5729-5731.2003 · Cited by 107
Martinez, R. M., & Wolk, D. M. (2016) · Microbiology Spectrum · doi:10.1128/microbiolspec.dmih2-0031-2016 · Cited by 124
The emergence of non-albicans Candida species as causes of invasive candidiasis and candidemia
Sobel, J. D. (2006) · Current Infectious Disease Reports · doi:10.1007/s11908-006-0016-6 · Cited by 127
Epidemiology of invasive fungal infection
Castón, J. J., Rivero, A., & Torre‐Cisneros, J. (2008) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(08)70009-8 · Cited by 117
Chi, H.-W., Yang, Y.-S., Shang, S.-T., Chen, K.-H., Yeh, K.-M., Chang, F.-Y., & Lin, J.-C. (2011) · Journal of Microbiology, Immunology and Infection · doi:10.1016/j.jmii.2010.08.010 · Cited by 103
Shorr, A. F., Lazarus, D. R., Sherner, J. H., Jackson, W. L., Morrel, M., Fraser, V. J., & Kollef, M. H. (2007) · Critical Care Medicine · doi:10.1097/01.ccm.0000259379.97694.00 · Cited by 101
Rodríguez‐Créixems, M., Alcalá, L., Muñóz, P., Cercenado, E., Vicente, T., & Bouza, E. (2008) · Medicine · doi:10.1097/md.0b013e318182119b · Cited by 126
Dimopoulos, G., Karabinis, A., Samonis, G., & Falagas, M. E. (2007) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-007-0316-2 · Cited by 97
Weinberger, M., Leibovici, L., Perez, S., Samra, Z., Ostfeld, I., Levi, I., Bash, E., Turner, D., Goldschmied‐Reouven, A., Regev‐Yochay, G., et al. (2005) · Journal of Hospital Infection · doi:10.1016/j.jhin.2005.02.009 · Cited by 109
Hospital Resource Utilization and Costs of Inappropriate Treatment of Candidemia
Arnold, H. M., Micek, S. T., Shorr, A. F., Zilberberg, M. D., Labelle, A. J., Kothari, S., & Kollef, M. H. (2010) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.30.4.361 · Cited by 94
Secular trend in candidemia and the use of fluconazole in Finland, 2004-2007
Poikonen, E., Lyytikäinen, O., Anttila, V.-J., Koivula, I., Lumio, J., Kotilainen, P., Syrjälä, H., & Ruutu, P. (2010) · BMC Infectious Diseases · doi:10.1186/1471-2334-10-312 · Cited by 93
Incidence of candidaemia and relationship with fluconazole use in an intensive care unit
Bassetti, M., Ansaldi, F., Nicolini, L., Malfatto, E., Molinari, M. P., Mussap, M., Rebesco, B., Bobbio Pallavicini, F., Icardi, G., & Viscoli, C. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp251 · Cited by 92
Antifungal Therapy in Children With Invasive Fungal Infections: A Systematic Review
Blyth, C. C., Palasanthiran, P., & O'Brien, T. A. (2007) · PEDIATRICS · doi:10.1542/peds.2006-2931 · Cited by 105
Epidemiology of Candidemia at a Children's Hospital, 2002 to 2006
Neu, N., Malik, M., Lunding, A., Whittier, S., Alba, L., Kubin, C., & Saiman, L. (2009) · Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e3181a0d78d · Cited by 92
Supplement: Trends in invasive Candida infections and their treatment: focus on echinocandins
(2009) · Current Medical Research and Opinion · doi:10.1185/03007990902990817 · Cited by 89
Echinocandins in the management of invasive fungal infections, part 1
Morris, M. I., & Villmann, M. (2006) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp050464.p1 · Cited by 86
Pfaller, M. A., Messer, S. A., Boyken, L., Tendolkar, S., Hollis, R. J., & Diekema, D. J. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.5.2176-2179.2003 · Cited by 86
Azole Resistance in Candida glabrata
Whaley, S. G., & Rogers, P. D. (2016) · Current Infectious Disease Reports · doi:10.1007/s11908-016-0554-5 · Cited by 85
Bhattacharjee, P. (2016) · Current Medical Mycology · doi:10.18869/acadpub.cmm.2.2.5 · Cited by 121
Invasive Candidiasis: An Overview from Taiwan
Ruan, S., & Hsueh, P. (2009) · Journal of the Formosan Medical Association · doi:10.1016/s0929-6646(09)60091-7 · Cited by 94
Current Options in Antifungal Pharmacotherapy
Mohr, J., Johnson, M., Cooper, T., Lewis, J. S., & Ostrosky‐Zeichner, L. (2008) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.28.5.614 · Cited by 84
Management of Invasive Candidiasis in Critically Ill Patients
Blot, S. I., & Vandewoude, K. (2004) · Drugs · doi:10.2165/00003495-200464190-00002 · Cited by 87
Alves, C. T., Wei, X., Silva, S. M., Azeredo, J., Henriques, M., & Williams, D. W. (2014) · Journal of Infection · doi:10.1016/j.jinf.2014.06.002 · Cited by 102
Wu, C., Lee, H., Lee, N., Shih, H., Ko, N., Wang, L., & Ko, W. (2006) · PubMed · Cited by 82
Candida infections in the neonate
Chapman, R. L. (2003) · Current Opinion in Pediatrics · doi:10.1097/00008480-200302000-00016 · Cited by 82
Risk Factors for Fluconazole-Resistant Candida glabrata Bloodstream Infections
Lee, I., Fishman, N. O., Zaoutis, T. E., Morales, K. H., Weiner, M. G., Synnestvedt, M., Nachamkin, I., & Lautenbach, E. (2009) · Archives of Internal Medicine · doi:10.1001/archinte.169.4.379 · Cited by 81
Candida Species: New Insights into Biofilm Formation
Cuéllar-Cruz, M., López-Romero, E., Villagómez-Castro, J. C., & Ruiz-Baca, E. (2012) · Future Microbiology · doi:10.2217/fmb.12.48 · Cited by 80
Tsai, H.-F., Sammons, L. R., Zhang, X., Suffis, S. D., Su, Q., Myers, T. G., Marr, K. A., & Bennett, J. E. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00535-10 · Cited by 80
Pfaller, M. A., Diekema, D. J., Gibbs, D. L., Newell, V. A., Barton, R., Bijie, H., Bille, J., Chang, S.-C., da Luz Martins, M., Duse, A., et al. (2010) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2010.01.002 · Cited by 80
Candida guilliermondii Fungemia in Patients with Hematologic Malignancies
Girmenia, C., Pizzarelli, G., Cristini, F., Barchiesi, F., Spreghini, E., Scalise, G., & Martino, P. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.00356-06 · Cited by 96
Fu, J., Ding, Y., Wei, B., Wang, L., Xu, S., Qin, P., Liuhua, W., & Jiang, L. (2017) · BMC Infectious Diseases · doi:10.1186/s12879-017-2423-8 · Cited by 89
Robles, J. C., Koreen, L., Park, S., & Perlin, D. S. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.6.2480-2488.2004 · Cited by 88
Has the Epidemiology of Nosocomial Candidemia Changed?
Puzniak, L., Teutsch, S., Powderly, W., & Polish, L. (2004) · Infection Control & Hospital Epidemiology · doi:10.1086/502452 · Cited by 80
Anidulafungin: A new echinocandin with a novel profile
Vazquez, J. A. (2005) · Clinical Therapeutics · doi:10.1016/j.clinthera.2005.06.010 · Cited by 78
Epidemiology, Incidence and Risk Factors for Invasive Candidiasis in High-Risk Patients
Concia, E., Azzini, A. M., & Conti, M. (2009) · Drugs · doi:10.2165/11315500-000000000-00000 · Cited by 87
Jacobsen, M. D., Gow, N. A. R., Maiden, M. C. J., Shaw, D. J., & Odds, F. C. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.01549-06 · Cited by 77
Studies on the antifungal properties of N-thiolated β-lactams
O’Driscoll, M., Greenhalgh, K., Young, A., Turos, E., Dickey, S. S., & Lim, D. V. (2008) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2008.06.035 · Cited by 84
Jensen, R. H., Johansen, H. K., Søes, L. M., Lemming, L. E., Rosenvinge, F. S., Nielsen, L., Olesen, B., Kristensen, L., Dzajic, E., Astvad, K. M. T., et al. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01763-15 · Cited by 77
Antifungal Activity of the Honeybee Products Against Candida spp. and Trichosporon spp.
Koç, A. N., Sılıcı, S., Kasap, F., Hörmet-Öz, H. T., Mavus-Buldu, H., & Erçal, B. D. (2010) · Journal of Medicinal Food · doi:10.1089/jmf.2009.0296 · Cited by 89
Silvestri, L., SAENE, H. K. F. V., Milanese, M., & Gregori, D. (2005) · Intensive Care Medicine · doi:10.1007/s00134-005-2654-9 · Cited by 78
Proteomics of drug resistance in Candida glabrata biofilms
Seneviratne, C. J., Wang, Y., Jin, L., Abiko, Y., & Samaranayake, L. P. (2010) · PROTEOMICS · doi:10.1002/pmic.200900611 · Cited by 74
Therapy and outcome of Candida glabrata versus Candida albicans bloodstream infection
Klevay, M. J., Ernst, E. J., Hollanbaugh, J. L., Miller, J. G., Pfaller, M. A., & Diekema, D. J. (2008) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2007.10.001 · Cited by 73
Al-Abdalall, A. A. (2010) · Journal of Family and Community Medicine · doi:10.4103/1319-1683.68783 · Cited by 92
European expert opinion on the management of invasive candidiasis in adults
Kullberg, B. J., Verweij, P. E., Akova, M., Arendrup, M. C., Billé, J., Calandra, T., Cuenca‐Estrella, M., Herbrecht, R., Jacobs, F., Kalin, M., et al. (2011) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03615.x · Cited by 78
Assessment of herbal drugs for promising anti-Candida activity
Soliman, S. S. M., Semreen, M. H., El‐Keblawy, A. A., Abdullah, A., Uppuluri, P., & Ibrahim, A. S. (2017) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-017-1760-x · Cited by 82
Cisterna, R., Ezpeleta, G., Telleria, O., Guinea, J., Regueiro, B., Garcia-Rodríguez, J., & Esperalba, J. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.00920-10 · Cited by 72
RetractedEffect of fluconazole consumption on long-term trends in candidal ecology
Blot, S. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl241 · Cited by 72
Davis, S. L., Vazquez, J. A., & Mckinnon, P. S. (2007) · Annals of Pharmacotherapy · doi:10.1345/aph.1h516 · Cited by 71
Occurrence, presentation and treatment of candidemia
Mikulska, M., Del Bono, V., Ratto, S., & Viscoli, C. (2012) · Expert Review of Clinical Immunology · doi:10.1586/eci.12.52 · Cited by 71
Abelson, J. A., Moore, T. B., Bruckner, D. A., Deville, J. G., & Nielsen, K. (2005) · PEDIATRICS · doi:10.1542/peds.2004-1605 · Cited by 76
Evaluating prophylaxis of invasive fungal infections in patients with haematologic malignancies
Maertens, J. A. (2006) · European Journal Of Haematology · doi:10.1111/j.1600-0609.2006.00805.x · Cited by 71
Liposomal amphotericin B: what is its role in 2008?
Lanternier, F., & Lortholary, O. (2008) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2008.01984.x · Cited by 78
Moran, C., Grussemeyer, C. A., Spalding, J. R., Benjamin, D. K., & Reed, S. D. (2009) · Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e3181920ffd · Cited by 70
Canadian Clinical Practice Guidelines for Invasive Candidiasis in Adults
Bow, E. J., Evans, G., Fuller, J., Laverdière, M., Rotstein, C., Rennie, R., Shafran, S. D., Sheppard, D., Carle, S., Phillips, P., et al. (2010) · Canadian Journal of Infectious Diseases and Medical Microbiology · doi:10.1155/2010/357076 · Cited by 70
Management of candidiasis in the intensive care unit
Schelenz, S. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm430 · Cited by 69
Motta, A. L., de Almeida, G. M. D., de Almeida Júnior, J. N., Burattini, M. N., & Rossi, F. (2010) · The Brazilian Journal of Infectious Diseases · doi:10.1016/s1413-8670(10)70091-x · Cited by 70
Holley, A., Dulhunty, J. M., Blot, S. I., Lipman, J., Lobo, S. M., Dancer, C., Rello, J., & Dimopoulos, G. (2009) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2008.10.035 · Cited by 81
Oral Candidosis in HIV-Infected Patients
Egusa, H., Soysa, N. S., Ellepola, A. N. B., Yatani, H., & Samaranayake, L. P. (2008) · Current HIV Research · doi:10.2174/157016208786501445 · Cited by 80
Novel strategies to fightCandidaspecies infection
Rodrigues, M. E., Silva, S. M., Azeredo, J., & Henriques, M. (2014) · Critical Reviews in Microbiology · doi:10.3109/1040841x.2014.974500 · Cited by 78
Antifungals to treatCandida albicans
Moudgal, V. V., & Sobel, J. D. (2010) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2010.493875 · Cited by 85
Taj‐Aldeen, S. J., Kolecka, A., Boesten, R., Alolaqi, A., Almaslamani, M., Chandra, P., Meis, J. F. G. M., & Boekhout, T. (2013) · Infection · doi:10.1007/s15010-013-0570-4 · Cited by 81
Rapid Identification of Commonly EncounteredCandidaSpecies Directly from Blood Culture Bottles
Selvarangan, R., Bui, U. T. T., Limaye, A. P., & Cookson, B. T. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.12.5660-5664.2003 · Cited by 76
Nosocomial candidaemia in children: results of a 9‐year study
Çelebi, S., HACIMUSTAFAOĞLU, M. K., Özdemır, Ö., & Özkaya, G. (2007) · Mycoses · doi:10.1111/j.1439-0507.2007.01464.x · Cited by 73
B, V. H., Bruynseels, P., Bensaid, M., Boekhout, T., Baere, T. D., Surmont, I., & Mertens, A. (2011) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-011-1383-y · Cited by 73
Prevention and Treatment of Candida Infections in Neonates
Chapman, R. L. (2007) · Seminars in Perinatology · doi:10.1053/j.semperi.2007.01.006 · Cited by 64
Micafungin: A New Echinocandin Antifungal
Joseph, J., Jain, R., & Danziger, L. H. (2007) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.27.1.53 · Cited by 69
Molecular Methods for the Diagnosis of Invasive Candidiasis
Camp, I., Spettel, K., & Willinger, B. (2020) · Journal of Fungi · doi:10.3390/jof6030101 · Cited by 75
Brisse, S., Pannier, C., Angoulvant, A., de Meeus, T., Diancourt, L., Faure, O., Muller, H., Peman, J., Viviani, M. A., Grillot, R., et al. (2009) · Eukaryotic Cell · doi:10.1128/ec.00215-08 · Cited by 64
Braga-Silva, L. A., & dos Santos, A. L. S. (2011) · Current Medicinal Chemistry · doi:10.2174/092986711795843182 · Cited by 66
The value of amphotericin B in the treatment of invasive fungal infections
Klepser, M. E. (2010) · Journal of Critical Care · doi:10.1016/j.jcrc.2010.08.005 · Cited by 77
Fungal Sepsis: Optimizing Antifungal Therapy in the Critical Care Setting
Lepak, A., & Andes, D. (2011) · Critical Care Clinics · doi:10.1016/j.ccc.2010.11.001 · Cited by 62
Nosocomial Candidemia: An Ounce of Prevention Is Better Than a Pound of Cure
Diekema, D. J., & Pfaller, M. A. (2004) · Infection Control and Hospital Epidemiology · doi:10.1086/502451 · Cited by 67
Lockhart, S. R., Wagner, D., Iqbal, N., Pappas, P. G., Andes, D. R., Kauffman, C. A., Brumble, L. M., Hadley, S., Walker, R., Ito, J. I., et al. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.02474-10 · Cited by 61
Koc, A. N., Silici, S., Ercal, B. D., Kasap, F., Hörmet-Öz, H. T., & Mavus-Buldu, H. (2009) · Medical Mycology · doi:10.3109/13693780802572554 · Cited by 61
Presterl, E., Daxböck, F., Graninger, W. B., & Willinger, B. (2007) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2007.01812.x · Cited by 63
Burden of hospitalization of patients with Candida and Aspergillus infections in Australia
Slavin, M. A., Fastenau, J. M., Sukarom, I., Mavros, P., Crowley, S. J., & Gerth, W. C. (2003) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2003.05.001 · Cited by 69
Sepehri, G. (2009) · American Journal of Applied Sciences · doi:10.3844/ajassp.2009.806.810 · Cited by 61
Skn7p is involved in oxidative stress response and virulence of Candida glabrata
Saijo, T., Miyazaki, T., Izumikawa, K., Mihara, T., Takazono, T., Kosai, K., Imamura, Y., Seki, M., Kakeya, H., Yamamoto, Y., et al. (2010) · Mycopathologia · doi:10.1007/s11046-009-9233-5 · Cited by 59
Bone Wax as a Risk Factor for Surgical-Site Infection Following Neurospinal Surgery
Gibbs, L., Kakis, A., Weinstein, P. R., & Conte, J. E. (2004) · Infection Control and Hospital Epidemiology · doi:10.1086/502403 · Cited by 65
Lott, T. J., Frade, J. P., & Lockhart, S. R. (2010) · Eukaryotic Cell · doi:10.1128/ec.00002-10 · Cited by 58
Dupont, B. F., Lortholary, O., Ostrosky-Zeichner, L., Stucker, F., & Yeldandi, V. (2009) · Critical Care · doi:10.1186/cc8117 · Cited by 58
Pourakbari, B., Sadr, A., Ashtıani, M. T. H., Mamishi, S., Dehghani, M., Mahmoudi, S., Salavati, A., & Asgari, F. (2011) · The Journal of Infection in Developing Countries · doi:10.3855/jidc.1517 · Cited by 63
A Review on the Clinical Use of Inhaled Amphotericin B
Kuiper, L., & Ruijgrok, E. J. (2009) · Journal of Aerosol Medicine and Pulmonary Drug Delivery · doi:10.1089/jamp.2008.0715 · Cited by 58
Treatment of Candida Infections with Amphotericin B Lipid Complex
Ito, J. I., & Hooshmand-Rad, R. (2005) · Clinical Infectious Diseases · doi:10.1086/429330 · Cited by 58
Association between multiple sclerosis and Candida species: evidence from a case-control study
Benito‐León, J., Pisa, D., Alonso, R., Calleja, P., Díaz-Sánchez, M., & Carrasco, L. (2010) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-010-0979-y · Cited by 62
Hsu, D. I., Nguyen, M., Nguyen, L., Law, A. V., & Wong‐Beringer, A. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq216 · Cited by 62
Detection of Fifteen Species of Candida in an Automated Blood Culture System
Horvath, L. L., George, B. J., & Hospenthal, D. R. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.00966-07 · Cited by 64
Metadata
- Authors
- Trick, W. E., Fridkin, S. K., Edwards, J. R., Hajjeh, R. A., Gaynes, R. P., & Hospitals, T. N. N. I. S. S.
- Affiliations
- Centers for Disease Control and Prevention (US)
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2002-09
- Volume
- 35
- Issue
- 5
- Pages
- 627-630
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2121025359
- Cited by
- 660
- References
- 19
- Citations by year
- 2026: 1 · 2025: 5 · 2024: 5 · 2023: 7 · 2022: 8 · 2021: 9 · 2020: 10 · 2019: 12 · 2018: 9 · 2017: 13 · 2016: 23 · 2015: 34 · 2014: 31 · 2013: 32 · 2012: 32
- FWCI
- 22.52
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Nosocomial Infections in ICU
- Health Sciences › Medicine › Infectious Diseases › Infection Control in Healthcare
- Keywords
- Candida albicans, Candida glabrata, non-albicans Candida, bloodstream infection, intensive care unit patients, nosocomial infections, incidence trends, National Nosocomial Infections Surveillance System
- MeSH terms
- Adult, Candida, Candidiasis, Cross Infection, Female, Humans, Intensive Care Units, Male, Middle Aged, United States
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.